Articles & Video
Emerging Therapies Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the most exciting developments in emerging therapies with one simple registration.
Novel Antibody Therapeutic Modalities - Antibody Therapeutics eBook Series
We take an in-depth look at the novel antibody therapeutic modalities being developed and how they are tackling new non-cancer targets in this Antibody Therapeutics eBook.
Report: Partnering And Deal-Making in Pharma through the Pandemic
This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.
REPORT: The Future of Healthcare Post COVID-19
In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months
How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.
Podcast: How to Create the Ultimate Bispecific
What goes into making the perfect bispecific? In our first Life Sciences podcast, we find out the best steps from Volker Schellenberger at Amunix.
Strategies to Innovate the Production of Next Generation Bioconjugates
From developing ADCs to tumor-targeting, this whitepaper reviews the latest common challenges and novel strategies for producing bioconjugates.
Future Trends in Proteins To Fight COVID-19
The whitepaper presents new case studies exposing the growing opportunities in protein therapeutics to treat COVID-19.
REPORT: Antibody Therapeutic Modalities 2020
Global research study into the development, targets, challenges and technologies of different antibody therapeutic modalities.
The role of COVID-19 antibody testing for employers
How can widespread COVID-19 antibody testing help reopen offices and how close are we to achieving it?
COVID-19 antibody therapeutic development - WHITEPAPER
This paper evaluates the antibody therapies for COVID-19 currently in clinical trials and preclinical development.
COVID-19 Report: The Response to and Impacts on the Global Life Sciences Industry
COVID-19 Report: How is the life sciences industry developing a vaccine, treatment and testing for COVID-19 and what impact is it having on supply chain?
Antibody Engineering and Therapeutics Survey: Tell us your views
Take part in our huge antibody therapeutic modalities survey to be in with a chance of winning a free conference pass.
Next Gen protein drug challenges and the latest technologies to overcome them - WHITEPAPER
This whitepaper looks at the main challenges facing protein-based therapeutics and the innovative new technologies and methods are being used to overcome them.
Engineering strategies for TCR and CAR-T cell therapies - WHITEPAPER
Engineering strategies for TCR and CAR-T cell therapies - download this whitepaper exploring the latest developments.
Novel technologies and approaches for optimizing antibody discovery - WHITEPAPER
This whitepaper examines some of the latest advancements in methods and technologies innovating the discovery of antibodies.
REPORT: Emerging Technologies and Novel Approaches in Antibody Engineering and Therapeutics
Download the data report exploring Emerging Technologies and Novel Approaches in Antibody Engineering and Therapeutics.
Emerging technologies in antibody engineering and therapeutics
This whitepaper looks at the latest emerging technologies and novel approaches to antibody engineering and therapeutics.
Designing novel protein therapeutics and identifying appropriate targets - WHITEPAPER
This whitepaper explores designing novel protein therapeutics and identifying appropriate targets - download it here.
Bispecific antibody engineering and therapeutics - WHITEPAPER
The whitepaper explores the latest developments, technologies and challenges in bispecific antibody engineering and therapeutics. Download it here.